The latest report by IMARC Group, titled “Aminoglycosides Market Report by Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, and Others), Route of Administration (Injectables (Parenteral), Intra-mammary, Topical, Oral, and Others), Application (Veterinary, Skin Infection, Respiratory Diseases, UTI and Pelvic Diseases, and Others), and Region 2024-2032“, The global aminoglycosides market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2032, exhibiting a growth rate (CAGR) of 2.66% during 2024-2032.
This group of antibiotics, known as aminoglycosides, plays a vital role in modern medicine. They have proven to be highly effective in combating a broad range of bacterial infections. By blocking the production of essential proteins within bacterial cells, aminoglycosides ultimately halt the growth and multiplication of these microorganisms. They are especially useful in tackling severe infections triggered by Gram-negative bacteria, including those that have developed resistance to other antibiotic classes. The potent ability of aminoglycosides to destroy bacteria makes them a valuable tool in hospital settings, where they are frequently used to treat infections associated with surgical procedures, burns, or life-threatening illnesses.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/aminoglycosides-market/requestsample
Aminoglycosides Market Trends and Drivers:
The ongoing rise in bacterial infections, particularly those caused by Gram-negative bacteria,minoglycosides. These antibiotics are very effective in treating various infections, ranging from urinary tract infections to severe respiratory conditions. The increasing presence of antibiotic-resistant bacterial strains highlights the importance of potent antibiotics like aminoglycosides. While some bacteria develop resistance to other antibiotics, aminoglycosides remain a reliable treatment choice, boosting their demand Not only that, aminoglycos vital in addressing hospital-acquired infections due to their wide-ranging effectiveness. In settings like intensive care units and surgical wards, where such infections present significant difficulties, the demand for these antibiotics remains consistently high. Furthermore, with a growing elderly population globally, there is an increased vulnerability to infections and associated complications. Aminoglycosides are extensively used in treating elderly patients with weakened immune systems, which propels market growth. Additionally, ongoing research has resulted in the creation of enhanced formulations that improve the efficacy and safety of aminoglycosides. These advancements broaden their utility in various medical contexts, contributing to market expansion.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Paromomycin
- Streptomycin
- Kanamycin
- Others
Breakup by Application:
- Veterinary
- Skin Infection
- Respiratory Diseases
- UTI and Pelvic Diseases
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Huvepharma NV
- Kremoint Pharma Pvt. Ltd.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- Vega Group company limited
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
